Last 12 months
Inside the activity.
7 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 7 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 26, 2023 Filed Apr 28, 2023 17:31 UTC |
Farrell Dawn LDirector
|
GrantCommon Stock | 5,858 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025991 · doc4.xml · nonDerivative · entry 1 Farrell Dawn L · CIK 0001645639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,773.84 F1 · balance_after: Includes directly owned shares, stock units and dividend equivalent units. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 13:01 UTC |
Phillips Sandra L.Director
|
GrantStock Units · Derivative | 835.0033 | $29.94 | $25,000.00 |
DisclosureSEC source: 0001209191-23-022042 · doc4.xml · derivative · entry 3 Rogers Sandra Phillips · CIK 0001721471 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,347.8162 Underlying: Common Stock · 835.0033 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable in 2028 per election under the Chemours deferred compensation plan for directors. F3 · derivative.expiration_date: Payable in 2028 per election under the Chemours deferred compensation plan for directors. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 16:46 UTC |
Kane Erin NDirector
|
GrantStock Units · Derivative | 835.0033 | $29.94 | $25,000.00 |
DisclosureSEC source: 0001209191-23-022037 · doc4.xml · derivative · entry 2 Kane Erin N · CIK 0001684077 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,700.8272 Underlying: Common Stock · 835.0033 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable upon separation of service. F3 · derivative.expiration_date: Payable upon separation of service. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 22:24 UTC |
Bellezza AlishaPresident, Thermal Spec Solns
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,936 | $0.00 Strike: $34.72 | $0.00 |
DisclosureSEC source: 0001209191-23-016876 · doc4.xml · derivative · entry 12 Bellezza Alisha · CIK 0001848483 · President, Thermal Spec Solns 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,936 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option award was granted on March 1, 2017 with vesting in three equal annual installments beginning March 1, 2018. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 22:24 UTC |
Bellezza AlishaPresident, Thermal Spec Solns
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,415 | $0.00 Strike: $25.98 | $0.00 |
DisclosureSEC source: 0001209191-23-016876 · doc4.xml · derivative · entry 11 Bellezza Alisha · CIK 0001848483 · President, Thermal Spec Solns 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,829 Underlying: Common Stock · 7,415 shares Expires 2032-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option award was granted on March 1, 2022 with vesting in three equal annual installments beginning March 1, 2023. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 22:24 UTC |
Bellezza AlishaPresident, Thermal Spec Solns
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,453 | $0.00 Strike: $24.01 | $0.00 |
DisclosureSEC source: 0001209191-23-016876 · doc4.xml · derivative · entry 10 Bellezza Alisha · CIK 0001848483 · President, Thermal Spec Solns 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,453 Underlying: Common Stock · 5,453 shares Expires 2031-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option award was granted on March 1, 2021 with vesting in three equal annual installments beginning March 1, 2022. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 22:24 UTC |
Bellezza AlishaPresident, Thermal Spec Solns
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,912 | $0.00 Strike: $14.43 | $0.00 |
DisclosureSEC source: 0001209191-23-016876 · doc4.xml · derivative · entry 9 Bellezza Alisha · CIK 0001848483 · President, Thermal Spec Solns 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,912 shares Expires 2030-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option award was granted on March 2, 2020 with vesting in three equal annual installments beginning March 2, 2021. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 22:24 UTC |
Bellezza AlishaPresident, Thermal Spec Solns
|
SaleCommon Stock | 5,936 | $35.47 | $210,549.92 |
DisclosureSEC source: 0001209191-23-016876 · doc4.xml · nonDerivative · entry 8 Bellezza Alisha · CIK 0001848483 · President, Thermal Spec Solns 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,930.857 F2 · price: Shares were sold in multiple transactions at prices ranging from $35.41 to $35.65. F1 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 22:24 UTC |
Bellezza AlishaPresident, Thermal Spec Solns
|
Exercise / conversionCommon Stock | 5,936 | $34.72 | $206,097.92 |
DisclosureSEC source: 0001209191-23-016876 · doc4.xml · nonDerivative · entry 7 Bellezza Alisha · CIK 0001848483 · President, Thermal Spec Solns 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,866.857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 22:24 UTC |
Bellezza AlishaPresident, Thermal Spec Solns
|
SaleCommon Stock | 7,415 | $35.47 | $263,010.05 |
DisclosureSEC source: 0001209191-23-016876 · doc4.xml · nonDerivative · entry 6 Bellezza Alisha · CIK 0001848483 · President, Thermal Spec Solns 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,930.857 F2 · price: Shares were sold in multiple transactions at prices ranging from $35.41 to $35.65. F1 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 22:24 UTC |
Bellezza AlishaPresident, Thermal Spec Solns
|
Exercise / conversionCommon Stock | 7,415 | $25.98 | $192,641.70 |
DisclosureSEC source: 0001209191-23-016876 · doc4.xml · nonDerivative · entry 5 Bellezza Alisha · CIK 0001848483 · President, Thermal Spec Solns 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,345.857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 22:24 UTC |
Bellezza AlishaPresident, Thermal Spec Solns
|
SaleCommon Stock | 5,453 | $35.47 | $193,417.91 |
DisclosureSEC source: 0001209191-23-016876 · doc4.xml · nonDerivative · entry 4 Bellezza Alisha · CIK 0001848483 · President, Thermal Spec Solns 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,930.857 F2 · price: Shares were sold in multiple transactions at prices ranging from $35.41 to $35.65. F1 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 22:24 UTC |
Bellezza AlishaPresident, Thermal Spec Solns
|
Exercise / conversionCommon Stock | 5,453 | $24.01 | $130,926.53 |
DisclosureSEC source: 0001209191-23-016876 · doc4.xml · nonDerivative · entry 3 Bellezza Alisha · CIK 0001848483 · President, Thermal Spec Solns 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,383.857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 22:24 UTC |
Bellezza AlishaPresident, Thermal Spec Solns
|
SaleCommon Stock | 8,912 | $35.47 | $316,108.64 |
DisclosureSEC source: 0001209191-23-016876 · doc4.xml · nonDerivative · entry 2 Bellezza Alisha · CIK 0001848483 · President, Thermal Spec Solns 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,930.857 F2 · price: Shares were sold in multiple transactions at prices ranging from $35.41 to $35.65. F1 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 22:24 UTC |
Bellezza AlishaPresident, Thermal Spec Solns
|
Exercise / conversionCommon Stock | 8,912 | $14.43 | $128,600.16 |
DisclosureSEC source: 0001209191-23-016876 · doc4.xml · nonDerivative · entry 1 Bellezza Alisha · CIK 0001848483 · President, Thermal Spec Solns 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,842.857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 20:47 UTC |
Wisel CamelaVP, CAO & Controller
|
Tax withholdingCommon Stock | 487 | $36.12 | $17,590.44 |
DisclosureSEC source: 0001209191-23-016079 · doc4.xml · nonDerivative · entry 3 Wisel Camela · CIK 0001886003 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,660.8853 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 20:47 UTC |
Sparks Edwin CPresident, Titan Tech Chem Sol
|
Tax withholdingCommon Stock | 18,079 | $36.12 | $653,013.48 |
DisclosureSEC source: 0001209191-23-016081 · doc4.xml · nonDerivative · entry 3 Sparks Edwin C · CIK 0001735771 · President, Titan Tech Chem Sol 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,243.7361 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 02:07 UTC |
Wellman Kristine MSVP, GC & Corp. Secretary
|
Tax withholdingCommon Stock | 517 | $36.12 | $18,674.04 |
DisclosureSEC source: 0001209191-23-016098 · doc4.xml · nonDerivative · entry 3 Wellman Kristine M · CIK 0001948665 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,618.817 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 02:04 UTC |
Dignam DenisePresident, Adv Perf Materials
|
Tax withholdingCommon Stock | 569 | $36.12 | $20,552.28 |
DisclosureSEC source: 0001209191-23-016095 · doc4.xml · nonDerivative · entry 4 Dignam Denise · CIK 0001848475 · President, Adv Perf Materials 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,216.4596 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 02:01 UTC |
Bellezza AlishaPresident, Thermal Spec Solns
|
Tax withholdingCommon Stock | 943 | $36.12 | $34,061.16 |
DisclosureSEC source: 0001209191-23-016094 · doc4.xml · nonDerivative · entry 3 Bellezza Alisha · CIK 0001848483 · President, Thermal Spec Solns 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,930.857 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 01:49 UTC |
Scarborough AlveniaSVP Corp Communications & CBO
|
Tax withholdingCommon Stock | 560 | $36.12 | $20,227.20 |
DisclosureSEC source: 0001209191-23-016083 · doc4.xml · nonDerivative · entry 3 Scarborough Alvenia · CIK 0001826993 · SVP Corp Communications & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,872.673 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 20:47 UTC |
Wisel CamelaVP, CAO & Controller
|
GrantPerformance Stock Option (Right to Buy) · Derivative | 4,813 | $0.00 Strike: $38.32 | $0.00 |
DisclosureSEC source: 0001209191-23-016079 · doc4.xml · derivative · entry 5 Wisel Camela · CIK 0001886003 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,813 Underlying: Common Stock · 4,813 shares Expires 2033-03-01 F5 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 20:47 UTC |
Wisel CamelaVP, CAO & Controller
|
GrantStock Option (Right to Buy) · Derivative | 4,882 | $0.00 Strike: $34.84 | $0.00 |
DisclosureSEC source: 0001209191-23-016079 · doc4.xml · derivative · entry 4 Wisel Camela · CIK 0001886003 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,882 Underlying: Common Stock · 4,882 shares Expires 2033-03-01 F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 20:47 UTC |
Wisel CamelaVP, CAO & Controller
|
GrantCommon Stock | 2,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016079 · doc4.xml · nonDerivative · entry 2 Wisel Camela · CIK 0001886003 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,147.8853 F3 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2024. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 20:47 UTC |
Wisel CamelaVP, CAO & Controller
|
Tax withholdingCommon Stock | 564 | $34.84 | $19,649.76 |
DisclosureSEC source: 0001209191-23-016079 · doc4.xml · nonDerivative · entry 1 Wisel Camela · CIK 0001886003 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,995.8853 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 20:47 UTC |
Sparks Edwin CPresident, Titan Tech Chem Sol
|
GrantPerformance Stock Option (Right to Buy) · Derivative | 17,650 | $0.00 Strike: $38.32 | $0.00 |
DisclosureSEC source: 0001209191-23-016081 · doc4.xml · derivative · entry 5 Sparks Edwin C · CIK 0001735771 · President, Titan Tech Chem Sol 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,650 Underlying: Common Stock · 17,650 shares Expires 2033-03-01 F5 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 20:47 UTC |
Sparks Edwin CPresident, Titan Tech Chem Sol
|
GrantStock Option (Right to Buy) · Derivative | 17,903 | $0.00 Strike: $34.84 | $0.00 |
DisclosureSEC source: 0001209191-23-016081 · doc4.xml · derivative · entry 4 Sparks Edwin C · CIK 0001735771 · President, Titan Tech Chem Sol 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,903 Underlying: Common Stock · 17,903 shares Expires 2033-03-01 F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 20:47 UTC |
Sparks Edwin CPresident, Titan Tech Chem Sol
|
GrantCommon Stock | 7,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016081 · doc4.xml · nonDerivative · entry 2 Sparks Edwin C · CIK 0001735771 · President, Titan Tech Chem Sol 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,322.7361 F3 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2024. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 20:47 UTC |
Sparks Edwin CPresident, Titan Tech Chem Sol
|
Tax withholdingCommon Stock | 1,309 | $34.84 | $45,605.56 |
DisclosureSEC source: 0001209191-23-016081 · doc4.xml · nonDerivative · entry 1 Sparks Edwin C · CIK 0001735771 · President, Titan Tech Chem Sol 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,429.7361 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:09 UTC |
Newman MarkDirector · President and CEO
|
GrantPerformance Stock Option (Right to Buy) · Derivative | 96,277 | $0.00 Strike: $38.32 | $0.00 |
DisclosureSEC source: 0001209191-23-016099 · doc4.xml · derivative · entry 6 Newman Mark · CIK 0001524597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,277 Underlying: Common Stock · 96,277 shares Expires 2033-03-01 F5 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:09 UTC |
Newman MarkDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 97,656 | $0.00 Strike: $34.84 | $0.00 |
DisclosureSEC source: 0001209191-23-016099 · doc4.xml · derivative · entry 5 Newman Mark · CIK 0001524597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,656 Underlying: Common Stock · 97,656 shares Expires 2033-03-01 F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:09 UTC |
Newman MarkDirector · President and CEO
|
GrantCommon Stock | 43,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016099 · doc4.xml · nonDerivative · entry 2 Newman Mark · CIK 0001524597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,171.8979 F3 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:09 UTC |
Newman MarkDirector · President and CEO
|
Tax withholdingCommon Stock | 5,248 | $34.84 | $182,840.32 |
DisclosureSEC source: 0001209191-23-016099 · doc4.xml · nonDerivative · entry 1 Newman Mark · CIK 0001524597 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,118.8979 F1 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2024. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:19 UTC |
Kelliher Susan M.SVP, People and Health Service
|
GrantPerformance Stock Option (Right to Buy) · Derivative | 11,232 | $0.00 Strike: $38.32 | $0.00 |
DisclosureSEC source: 0001209191-23-016104 · doc4.xml · derivative · entry 4 Kelliher Susan M. · CIK 0001568507 · SVP, People and Health Service 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,232 Underlying: Common Stock · 11,232 shares Expires 2033-03-01 F5 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:19 UTC |
Kelliher Susan M.SVP, People and Health Service
|
GrantStock Option (Right to Buy) · Derivative | 11,393 | $0.00 Strike: $34.84 | $0.00 |
DisclosureSEC source: 0001209191-23-016104 · doc4.xml · derivative · entry 3 Kelliher Susan M. · CIK 0001568507 · SVP, People and Health Service 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,393 Underlying: Common Stock · 11,393 shares Expires 2033-03-01 F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:19 UTC |
Kelliher Susan M.SVP, People and Health Service
|
GrantCommon Stock | 5,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016104 · doc4.xml · nonDerivative · entry 2 Kelliher Susan M. · CIK 0001568507 · SVP, People and Health Service 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,275.8412 F3 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2024. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:19 UTC |
Kelliher Susan M.SVP, People and Health Service
|
Tax withholdingCommon Stock | 921 | $34.84 | $32,087.64 |
DisclosureSEC source: 0001209191-23-016104 · doc4.xml · nonDerivative · entry 1 Kelliher Susan M. · CIK 0001568507 · SVP, People and Health Service 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,253.8412 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:18 UTC |
Lock JonathanSVP, Chief Development Officer
|
GrantPerformance Stock Option (Right to Buy) · Derivative | 6,819 | $0.00 Strike: $38.32 | $0.00 |
DisclosureSEC source: 0001209191-23-016103 · doc4.xml · derivative · entry 4 Lock Jonathan · CIK 0001891480 · SVP, Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,819 Underlying: Common Stock · 6,819 shares Expires 2033-03-01 F5 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:18 UTC |
Lock JonathanSVP, Chief Development Officer
|
GrantStock Option (Right to Buy) · Derivative | 6,917 | $0.00 Strike: $34.84 | $0.00 |
DisclosureSEC source: 0001209191-23-016103 · doc4.xml · derivative · entry 3 Lock Jonathan · CIK 0001891480 · SVP, Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,917 Underlying: Common Stock · 6,917 shares Expires 2033-03-01 F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:18 UTC |
Lock JonathanSVP, Chief Development Officer
|
GrantCommon Stock | 3,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016103 · doc4.xml · nonDerivative · entry 2 Lock Jonathan · CIK 0001891480 · SVP, Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,659.4423 F3 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2024. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:18 UTC |
Lock JonathanSVP, Chief Development Officer
|
Tax withholdingCommon Stock | 418 | $34.84 | $14,563.12 |
DisclosureSEC source: 0001209191-23-016103 · doc4.xml · nonDerivative · entry 1 Lock Jonathan · CIK 0001891480 · SVP, Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,610.4423 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:07 UTC |
Wellman Kristine MSVP, GC & Corp. Secretary
|
GrantPerformance Stock Option (Right to Buy) · Derivative | 10,430 | $0.00 Strike: $38.32 | $0.00 |
DisclosureSEC source: 0001209191-23-016098 · doc4.xml · derivative · entry 5 Wellman Kristine M · CIK 0001948665 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,430 Underlying: Common Stock · 10,430 shares Expires 2033-03-01 F5 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:07 UTC |
Wellman Kristine MSVP, GC & Corp. Secretary
|
GrantStock Option (Right to Buy) · Derivative | 10,579 | $0.00 Strike: $34.84 | $0.00 |
DisclosureSEC source: 0001209191-23-016098 · doc4.xml · derivative · entry 4 Wellman Kristine M · CIK 0001948665 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,579 Underlying: Common Stock · 10,579 shares Expires 2033-03-01 F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:07 UTC |
Wellman Kristine MSVP, GC & Corp. Secretary
|
GrantCommon Stock | 4,664 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016098 · doc4.xml · nonDerivative · entry 2 Wellman Kristine M · CIK 0001948665 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,135.817 F3 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2024. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:07 UTC |
Wellman Kristine MSVP, GC & Corp. Secretary
|
Tax withholdingCommon Stock | 1,088 | $34.84 | $37,905.92 |
DisclosureSEC source: 0001209191-23-016098 · doc4.xml · nonDerivative · entry 1 Wellman Kristine M · CIK 0001948665 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,471.817 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:06 UTC |
Ralhan SameerSVP, CFO
|
GrantPerformance Stock Options (Right to Buy) · Derivative | 27,679 | $0.00 Strike: $38.32 | $0.00 |
DisclosureSEC source: 0001209191-23-016096 · doc4.xml · derivative · entry 4 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,679 Underlying: Common Stock · 27,679 shares Expires 2033-03-01 F5 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:06 UTC |
Ralhan SameerSVP, CFO
|
GrantStock Option (Right to Buy) · Derivative | 28,076 | $0.00 Strike: $34.84 | $0.00 |
DisclosureSEC source: 0001209191-23-016096 · doc4.xml · derivative · entry 3 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,076 Underlying: Common Stock · 28,076 shares Expires 2033-03-01 F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:06 UTC |
Ralhan SameerSVP, CFO
|
GrantCommon Stock | 12,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016096 · doc4.xml · nonDerivative · entry 2 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 381,345.8611 F3 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2024. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:06 UTC |
Ralhan SameerSVP, CFO
|
Tax withholdingCommon Stock | 1,842 | $34.84 | $64,175.28 |
DisclosureSEC source: 0001209191-23-016096 · doc4.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,967.8611 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 02:04 UTC |
Dignam DenisePresident, Adv Perf Materials
|
GrantPerformance Stock Option (Right to Buy) · Derivative | 13,238 | $0.00 Strike: $38.32 | $0.00 |
DisclosureSEC source: 0001209191-23-016095 · doc4.xml · derivative · entry 6 Dignam Denise · CIK 0001848475 · President, Adv Perf Materials 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,238 Underlying: Common Stock · 13,238 shares Expires 2033-03-01 F6 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant F5 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.